Reconhecimento nacional por uma missão global.
Veja Saúde, one of Brazil’s leading publications in science and medical reporting, published a special feature this week highlighting the progress of the Medulloblastoma Initiative (MBI) and the beginning of a new phase for clinical trials in the country. In the article, experts emphasize the scientific and social impact of bringing experimental therapies for pediatric […]
O portal VivaBem / UOL destacou a trajetória da Medulloblastoma Initiative (MBI).
The article highlights the journey of Fernando Goldsztein and his son Frederico, a personal experience that led to the creation of an initiative that now brings together scientists, families, and institutions in a global effort to develop new therapies for medulloblastoma, a rare and aggressive pediatric brain tumor. By sharing the origins of the MBI, […]